CR2O Flyer 2016

CR2O Flyer 2016

• 1.
  CR2 O offers thefollowing Site Management services through our affiliated clinics and research centers. • Study feasibility, • Site selection & start-up (contracting and regulatory submissions), • Patient recruitment, • Site management. CR2 O offers the following Contract Research services, backed-up by our quality infrastructure. • Protocol development, • Study feasibility, • Site selection & start-up (contracting and regulatory submissions), • Clinical project management, • Patient recruitment, • Study monitoring and operations, • Site management, • Data management & statisticafety reporting, • Study reporting. Clinical Research Rotterdam Who we are CR2 O is an academic research organization that focusses on managing and operating clinical trials for vaccine-, drug-, and diagnostics development by industry and public organizations. Value proposition CR2 O offers the combined strengths of its affiliated centers and clinical operations capabilities as an overarching cutting edge service provider. Site Management services Contract Research services Aim A major objective of CR2 O is performing clinical and epidemiological research projects for vaccine industry. The transparent and knowledge-based infrastructure of CR2 O makes it an attractive and reliable contract partner. The management of CR2 O includes highly qualified scientists and business oriented clinical development professionals. This leads to the optimal combination of scientific expertise and industrial efficiency, satisfying the need of pharmaceutical industry to outsource clinical trial operations and monitoring. Scientific network CR2 O closely collaborates with leading clinics and research centers throughout Europe. Through our affiliated centers we aim to bring world-class academic expertise in viral and other infectious diseases, with state of the art clinical infrastructure and high quality research facilities (e.g. BSL 2-3 research and diagnostic labs). CR2 O participates in a worldwide network of virology stakeholders, providing us with a unique position to enter the field of clinical trials for infectious disease interventions, to test new generations of vaccines, drugs, and diagnostic approaches.
• 2.
  Clinical Research Rotterdam HadilEs-Sbai Chief Executive Officer Hadil assumed several roles within the pharmaceutical- and CRO industry, thereby acquiring extensive experience in managing international clinical trials within a wide range of therapeutic areas. Ab Osterhaus Chief Scientific Officer As professor of the Department of Viroscience at Erasmus MC Rotterdam, and professor of Wildlife Virology and Virus Discovery at Utrecht University, Ab has a long track record as scientific researcher and PI of numerous major scientific projects. Meet our team Rob Posthumus General Counsel With a background as head of the legal department of Erasmus university Medical Center Rotterdam, Rob acquired extensive experience drafting, negotiating and managing contracts in healthcare and the biotechnology sector. Eric Claassen Chief Financial Officer Eric is 10% academic and 90% entrepreneur. He has held numerous functions related to research management, valorization and business development in life sciences with a special emphasis on immunology (SMBWO board certified), microbiology. Inquiries For information on our services please contact [email protected] T: +31 6 450 77 441 CR2 O Rotterdam Science Tower Marconistraat 16 L-3029 AK Rotterdam The Netherlands www.CR2O.nl